CLAR
Clarus Corporation
CLAR has the edge over LCID overall, supported by lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
CLAR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Stable |
CLAR's revenue and balance sheet are currently stable, but its profitability and cash flow are under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CLAR PE Valuation
CLAR has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 29x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
CLAR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CLAR to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CLAR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.18 | — |
| Q3 2026 | -$0.69 | +$1.43 |
| Q2 2026 | -$0.82 | +$1.34 |
| Q1 2026 | -$1.16 | +$0.92 |
| Q4 2025 | -$1.21 | +$0.16 |
| Q3 2025 | -$2.12 | -1731% |
| Q2 2025 | -$2.16 | -1300% |
| Q1 2025 | -$2.08 | -900% |
| Q4 2024 | -$1.37 | -$1.10 |
CLAR is still losing money, but far less than before: $0.69 per share over the past year, against $2.22 at its worst in late 2023.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over CLAR on earnings, with more consistent year-over-year improvement.
CLAR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $71.2M | +2.7% |
| Q2 2026 | $56.2M | +1.6% |
| Q1 2026 | $61.9M | +2.5% |
| Q4 2025 | $65.4M | -8.4% |
| Q3 2025 | $69.3M | +3.3% |
| Q2 2025 | $55.2M | -2.2% |
| Q1 2025 | $60.4M | -13% |
| Q4 2024 | $71.4M | +1377% |
CLAR's revenue fell from its 2021 peak and has held roughly level since: $71M last quarter, up 2.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.7% | +9 points |
| Q2 2026 | 8.1% | +28 points |
| Q1 2026 | -9.8% | +1.4 points |
| Q4 2025 | -60% | +11 points |
| Q3 2025 | -4.4% | +3.6 points |
| Q2 2025 | -20% | -5.3 points |
| Q1 2025 | -11% | -1.4 points |
| Q4 2024 | -70% | +496 points |
CLAR has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over CLAR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
CLAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.4M | -$443K |
| Q2 2026 | $636K | +$11.9M |
| Q1 2026 | -$5.7M | -$2.4M |
| Q4 2025 | $11.6M | -19% |
| Q3 2025 | -$7M | +$2.4M |
| Q2 2025 | -$11.3M | -$10.6M |
| Q1 2025 | -$3.3M | +$15M |
| Q4 2024 | $14.4M | +8.2% |
CLAR has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
CLAR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | 2.9x | Moderate |
| Q2 2022 | 2.9x | Moderate |
| Q1 2022 | 3.2x | Elevated |
| Q4 2021 | 3.3x | Elevated |
| Q3 2021 | 5.8x | High |
| Q2 2021 | 0.7x | Very low |
| Q1 2021 | 1.2x | Healthy |
| Q4 2020 | 1.3x | Healthy |
CLAR's net debt is about 2.9 years of its operating earnings (EBITDA), down from 5.8 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CLAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 80.0 | Overbought |
| Stochastic | 89.2 | Overbought |
CLAR's weekly RSI is 80 (overbought) and its Stochastic is 89 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CLAR PE vs Consumer Cyclical Sector
| Metric | CLAR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CLAR has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
CLAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.07 | 27% above |
| 20 week MA | $3.74 | 38% above |
| 50 week MA | $3.38 | 53% above |
| 100 week MA | $3.58 | 44% above |
| 200 week MA | $5.20 | 0.6% below |
CLAR has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
CLAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.6 | $15.4 | +13% |
| 2021 | $15.4 | $26.7 | +73% |
| 2022 | $26.7 | $7.15 | -73% |
| 2023 | $7.15 | $6.90 | -3.5% |
| 2024 | $6.90 | $4.54 | -34% |
| 2025 | $4.54 | $3.38 | -26% |
| 2026 YTD | $3.38 | $5.17 | +53% |
CLAR has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.